16 Cochlear Implantation • A CI is a device implanted into the cochlea that directly stimulates nerve fibres within the auditory system, allowing the perception of sound (Fig. 16.1) • Paediatric: children with pre-lingual deafness have a critical period in which they can be usefully implanted (<2 years) for greatest benefit; those children (or adults) who lost hearing after language acquisition have established central auditory pathways so can be implanted up to 10 years after the onset of deafness: • Adult >18 years: • Audiometric: • Medical: • Procedure: • Device: • Does not provide normal hearing • Gradual improvement in performance especially in first 6 months, but for up to 2 years • 95% adults have improved lip-reading, 50% have acquired open-set speech discrimination, 35% can use telephone • 90% children aided <2 years enter mainstream education • Reliability: 97 to 99% functioning at 10 years • Which ear? • Bimodal stimulation; HA one ear, CI in the other • Bilateral CIs • Hybrid implants, “electroacoustic stimulation”
16.1 Principles
Stimulates cochlear n fibres (spiral ganglion cells) with acoustic sounds that have been processed into electrical energy
Primary aim is to provide user with greater speech recognition ability than is possible with conventional amplification
Microphone (worn like an HA) converts sound into electrical signals; speech processor analyzes and digitizes this information into coded signals (splitting into frequency bands); transmitter is held over receiver by a magnet and sends the code across the skin as radiofrequency waves; coded signal is converted to electrical signals that pass to the electrode to allow for stimulation of the nerve fibres (tonotopic arrangement)
Goal in children: to achieve age-appropriate speech, language, and listening skills; to reduce intervention over time; to have mainstream education; to be fully integrated into hearing world
Goal in adults: to support lip-reading; to improve communication ability and develop telephone and open-set speech; to reduce effort of communication; to be in touch with surroundings
16.2 Indications
Profound sensorineural hearing loss in both ears (e.g., unaided >90 dB across speech frequencies)
Lack of progress in the development of auditory skills
No medical contraindications
High motivation and appropriate expectations from family
Precise audiometric inclusion criteria vary from centre to centre and as experience in CI grows
Assess speech, language, and listening skills appropriate for age, developmental stage, and cognitive ability
Pre-linguistic or post-linguistic onset of severe-to-profound hearing loss
Audiometric criteria and exact test used to make assessment vary between centres
Consider when hearing worse than 90 dB HL at 2 and 4 Hz; adequate benefit from a conventional HA considered when >50% score on BKB (Bamford-Kowal-Bench) sentence testing at sound intensity of 70 dB SPL, so needs to be worse to justify CI
No medical contraindications
A desire to be part of the hearing world
16.3 Contraindications
Presence of significant residual hearing
Active infection (acute or chronic OM)
Ossified cochlea
Cochlea non-development
Unrealistic expectations
16.4 Surgery
General anaesthesia, mastoidectomy with posterior tympanotomy
Cochleostomy anteroinferior to round window membrane
Multi-channel electrodes generally used, with variable number of specific electrodes depending upon device used
Intra-operative testing with neural response telemetry, checks that implant is working and in contact with auditory n endings
Post-operative switch-on usually after ~4 to 6 weeks with continued “remapping” over next few years
Facial paresis/paralysis (temporary or permanent): 1:500 to 1:1000
Taste disturbance (temporary): 10%
Loss of residual hearing: dependent on surgical technique and implant used
Balance dysfunction/vertigo—temporary: most patients; long-term balance dysfunction rare
Infection: <1% but may/usually necessitate removal of implant
Meningitis—perioperative: 1:5000 (vaccinate vs. pneumoncoccus, Hib); long-term risk similar to general population
16.5 Expected Outcomes
16.6 Special Considerations
Better-hearing or worse-hearing ear, depending if plan for bimodal stimulation
HA use in implanted ear usually predictive of better performance than non-aided ear
Vestibular function
Helps in background noise, for sound localization, and allows for better music appreciation
Improved sound localization, speech understanding in quiet and noise
Guaranteed to implant better ear
Improved speech, language, and auditory development in children
If one fails, not completely isolated
Simultaneous bilateral CI recommended in adults and children, especially when codisability (e.g., blindness)
Shorter electrodes used for high tone loss with conventional HA for lower frequencies
< div class='tao-gold-member'>
Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree

